Issue Information
November 2013
in “
Cancer
”
TLDR Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.
This edition of the news section provided Cancer readers with insights into various topics, including the benefits of oophorectomy in reducing ovarian cancer risk for women with BRCA mutations, emphasizing the importance of counseling and support for these patients. It also highlighted a study confirming that finasteride reduced prostate cancer risk without increasing mortality risk. Additionally, it noted a significant increase in prophylactic mastectomy rates in the United States and discussed a new analysis aimed at predicting DCIS recurrence.
